| Date Checked | 2025-12-21 23:36:34 |
|---|---|
| Graham Number | (PB)110.30 vs (PE)151.09 |
| Over / Under Value Percentage | 716.08% vs 679.10% |
| Dividend Yield | 0.56% |
| Dividend Date | 2025-12-10 |
| Symbol | LLY |
| AssetType | Common Stock |
| Name | Eli Lilly and Company |
| Description | Eli Lilly and Company (Ticker: LLY), based in Indianapolis, Indiana, is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare. Specializing in critical therapeutic areas including diabetes, oncology, and neurodegenerative diseases, the company operates in around 125 countries, continually striving to enhance patient outcomes through substantial investments in research and development. With a strategic emphasis on sustainable growth, robust product pipeline advancements, and strategic partnerships, Lilly fortifies its status as a key player in the pharmaceutical industry, committed to advancing modern medicine while driving shareholder value. |
| CIK | 59478 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | LILLY CORPORATE CENTER, INDIANAPOLIS, IN, UNITED STATES, 46285 |
| OfficialSite | https://www.lilly.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 909446414000 |
| EBITDA | 28728601000 |
| PERatio | 49.83 |
| PEGRatio | 0.972 |
| BookValue | 26.56 |
| DividendPerShare | 5.8 |
| EPS | 20.36 |
| RevenuePerShareTTM | 66.15 |
| ProfitMargin | 0.31 |
| OperatingMarginTTM | 0.483 |
| ReturnOnAssetsTTM | 0.176 |
| ReturnOnEquityTTM | 0.965 |
| RevenueTTM | 59419800000 |
| GrossProfitTTM | 49335702000 |
| DilutedEPSTTM | 20.36 |
| QuarterlyEarningsGrowthYOY | 4.804 |
| QuarterlyRevenueGrowthYOY | 0.539 |
| AnalystTargetPrice | 1056.7 |
| AnalystRatingStrongBuy | 4 |
| AnalystRatingBuy | 17 |
| AnalystRatingHold | 8 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | 49.83 |
| ForwardPE | 32.57 |
| PriceToSalesRatioTTM | 15.31 |
| PriceToBookRatio | 38.88 |
| EVToRevenue | 16.12 |
| EVToEBITDA | 37.86 |
| Beta | 0.389 |
| 52WeekHigh | 1111.99 |
| 52WeekLow | 621.5 |
| 50DayMovingAverage | 900.17 |
| 200DayMovingAverage | 810.51 |
| SharesOutstanding | 895019000 |
| SharesFloat | 893127000 |
| PercentInsiders | 0.164 |
| PercentInstitutions | 83.190 |
| ExDividendDate | 2025-11-14 |
| dateChecked | 2025-12-21 23:36:34 |
| fresh | 1 |